The latest generation of the device has shown improvements over the first generation, which demonstrated the potential to reduce disc bulges and avoid low back surgery. The therapy is an injection procedure. Testing of the device will continue for improved disc penetration and steering for optimal cell placement.
The device is currently patent-pending and is designed as a needle/catheter delivery system to inject cells directly into the annular tear that is causing the bulge or herniation.
More Articles on Spine Devices:
VG Innovations Receives Patent for Spinal Facet Fusion System
15 Spine Device Company Leadership Moves
LDR Receives FDA 510(k) Clearance for ROI-Lordic Cervical Cage
BioRestorative Therapies Stem Cell Disc Deliver Device Shows ImprovementWritten by Laura Miller | May 04, 2012
Jupiter, Fla.-based company BioRestorative Therapies has announced improvements in the latest version of its stem cell disc delivery device, which is used for treating bulging and herniated discs.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.